200,000+ products from a single source!
sales@angenechem.com
Home > Fluorides > 168828-58-8
168828-58-8 | Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
CAS No: 168828-58-8 Catalog No: AG001YBA MDL No:MFCD00937821
Product Description
Catalog Number:
AG001YBA
Chemical Name:
Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
CAS Number:
168828-58-8
Molecular Formula:
C16H20FN3O3S
Molecular Weight:
353.4117
MDL Number:
MFCD00937821
IUPAC Name:
N-[[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
InChI:
InChI=1S/C16H20FN3O3S/c1-11(21)18-9-13-10-20(16(22)23-13)12-2-3-15(14(17)8-12)19-4-6-24-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1
InChI Key:
FNDDDNOJWPQCBZ-ZDUSSCGKSA-N
SMILES:
CC(=O)NC[C@@H]1OC(=O)N(C1)c1ccc(c(c1)F)N1CCSCC1
UNII:
3A71182L8P
NSC Number:
742407
Properties
Complexity:
476
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
353.121g/mol
Formal Charge:
0
Heavy Atom Count:
24
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
353.412g/mol
Monoisotopic Mass:
353.121g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
87.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5
Literature
| Title | Journal |
|---|---|
| In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates. | International journal of antimicrobial agents 20130701 |
| SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro. | The Journal of antimicrobial chemotherapy 20120501 |
| Tuberculosis: the drug development pipeline at a glance. | European journal of medicinal chemistry 20120501 |
| Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide. | PloS one 20120101 |
| Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers. | The Journal of infectious diseases 20100901 |
| Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis. | American journal of respiratory and critical care medicine 20090815 |
| Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. | Journal of medicinal chemistry 20080410 |
| New small-molecule synthetic antimycobacterials. | Antimicrobial agents and chemotherapy 20050601 |
| Short-course treatment regimen to identify potential antituberculous agents in a murine model of tuberculosis. | The Journal of antimicrobial chemotherapy 20040401 |
| Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480. | Bioorganic & medicinal chemistry letters 20040322 |
| Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model. | Antimicrobial agents and chemotherapy 19990501 |
| Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. | Journal of medicinal chemistry 19960202 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.